🇺🇸 FDA
Patent

US 10918594

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

granted A61KA61K31/00A61K31/167

Quick answer

US patent 10918594 (Controlled-release CNS modulating compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/00, A61K31/167, A61K31/195, A61K31/197